From fleet-level monitoring to faster quantitative workflows, new expectations are emerging for how mass spectrometry platforms support decision-making at scale.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.